Clinically studied results
average body weight loss*
A once-weekly GLP-1 treatment studied alongside lifestyle support.
*In a 68-week clinical study of branded Semaglutide 2.4 mg with lifestyle intervention, mean body weight change was 14.9%. Individual results vary. Compounded Semaglutide is not FDA-approved.
Results and experiences vary. Your provider determines whether treatment is appropriate.










